24-HOUR POSTER VIEWING
|
If you are in the Central time zone, subtract 1 hour, e.g., 11:00 AM EST is 10:00 AM CST
If you are in the Mountain time zone, subtract 2 hours, e.g., 11:00 AM EST is 9:00 AM MST
If you are in the Pacific time zone, subtract 3 hours, e.g., 11:00 AM EST is 8:00 AM PST
Monday - November 9, 2020 |
|
12:30 PM - 1:00 PM (EST) | Welcome & Introductions |
Plenary Session: Revolutionary Thinkers This joint plenary session kicks off the PISA 2020 virtual meeting: “Pathobiology that Drives Discovery, Diagnosis, and Treatment of Human Diseases: Present and Future”. The goal of “Revolutionary Thinkers” is to present insights from world-class research innovators at the leading edge of molecular and cellular pathobiology. |
|
1:00 PM - 1:30 PM (EST) |
Benjamin Ebert, MD, PhD • Dana-Farber/Harvard Cancer Center Dr. Ben Ebert is the Canellos Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at the Dana-Farber Cancer Institute, a Howard Hughes Medical Institute Investigator, and an Institute Member of the Broad Institute; outside his scientific interests, Ben is also a competitive cyclist and triathlete. His lab works on projects varying from the somatic mutations that drive clonal hematopoiesis of indeterminant potential (CHIP; a term that his group coined) to the genetics, biology, and clinical implications of myelodysplastic syndromes. Dr. Ebert will highlight novel therapies targeting the machinery of ubiquitin ligases and proteasomal degradation in catabolizing disease-related proteins. |
1:30 PM - 2:00 PM (EST) |
George Church, PhD • Harvard Medical School Dr. George Church is Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and MIT. He is Director of the U.S. Department of Energy Technology Center and Director of the National Institutes of Health Center of Excellence in Genomic Science. In 2012, he co-authored Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves (the NewScientist called it the "top science book" of the year), and champions open education and citizen science for synthetic biology and personal genomics. His group has developed technologies to synthesize whole genes and engineer whole genomes—far faster, more accurately, and with less cost than current methods. As lead of Synthetic Biology at the Wyss Institute, he oversees the directed evolution of molecules, polymers, and whole genomes to create new tools with applications in regenerative medicine and bio-production of chemicals. Dr. Church will illustrate new genomic technologies that can help to facilitate the next generation of “omics” investigation. |
2:00 PM - 2:30 PM (EST) |
Pardis Sabeti, MD, DPhil • Broad Institute Dr. Pardis Sabeti is a computational geneticist whose work focuses on developing algorithms to detect genetic signatures of adaption in microbial pathogens and their human hosts. She is a member of the Broad Institute, and a Howard Hughes Investigator Professor at the Center for Systems Biology and Department of Organismic and Evolutionary Biology at Harvard University and the Department of Immunology and Infectious Disease at the Harvard School of Public Health. She is also known as a rollerblading rock star scientist, was cited in 2015 as one of Time Magazine's 100 Most Influential people, and is the lead singer of the rock band Thousand Days. Dr. Sabeti will present an extremely topical discussion on the recognition and pre-emption of infectious disease outbreaks. |
2:30 PM - 2:45 PM (EST) | Questions and Answers |
2:45 PM - 3:00 PM (EST) | Break |
Symposia: Microglia: Dynamic and Complicated Players in Development and Disease Session Description: Microglia are resident innate immune cells in the central nervous system that generally serve a protective role in mediating responses to infection. They have additional diverse roles in synaptogenesis during development, synaptic integrity and turnover, neuronal support, and other injury repair processes. In pathological conditions, the roles of microglia are even more complex with recent evidence that neuron-glia interactions affect a variety of cellular processes often with both positive and negative consequences. In this session, we will discuss microglia dysfunction and neuroinflammation, explore the role of microglia as mediators or synapse loss, address disease-specific changes in the microglial sensome, and delve into complex regulatory mechanisms of microglia function in health and disease. |
|
3:00 PM - 3:30 PM (EST) | Joseph El Khoury, MD • Massachusetts General Hospital “Disease-Specific Changes in the Microglial Sensome” |
3:30 PM - 4:00 PM (EST) | Sebastian Werneburg, PhD • University of Massachusetts Medical School “Targeting Microglia-Mediated Synapse Elimination for Therapeutic Intervention in Demyelinating Disease” |
4:00 PM - 4:15 PM (EST) |
Abstract-Driven Short Talk |
4:15 PM - 4:30 PM (EST) |
Abstract Driven Short Talk |
4:30 PM - 4:45 PM (EST) |
Abstract-Driven Short Talk |
4:45 PM - 5:00 PM (EST) | Questions and Answers |
Symposia: Novel Insights into Hepatobiliary Repair Via Reprogramming and Microbiome Session Description: The term hepatobiliary injury encompasses a wide spectrum of diseases of the liver and biliary system, which can be caused by viral infections, alcohol, xenobiotic compounds, metabolic disorders, neoplasia, and autoimmune disorders, among others. Unfortunately, in many of these diseases, treatment is limited; thus, there is an urgent need to develop more effective therapeutic interventions. In this session, we will discuss the benefits of activating a cholangiocyte-like program in hepatocytes to promote biliary repair during cholestasis, explore the mechanism by which intestinal microbes protect against oxidative stress-induced liver injury, and investigate other novel mechanisms to ameliorate the pathophysiology of liver diseases. |
|
3:00 PM - 3:30 PM (EST) | Kari Nejak-Bowen, MBA, PhD • University of Pittsburgh “The Role of Wnt Signaling in Hepatocyte to Cholangiocyte Reprogramming” |
3:30 PM - 4:00 PM (EST) | Andrew Neish, MD • Emory University School of Medicine “Microbiota-Derived Metabolites Regulate Hepatic Cytoprotection” |
4:00 PM - 4:15 PM (EST) |
Abstract-Driven Short Talk |
4:15 PM - 4:30 PM (EST) |
Abstract-Driven Short Talk |
4:30 PM - 4:45 PM (EST) |
Abstract-Driven Short Talk |
4:45 PM - 5:00 PM (EST) | Questions and Answers |
5:00 PM - 6:00 PM | Break (View the ePosters) |
6:00 PM - 8:00 PM (EST) |
Trainee Hangout A virtual meeting can be difficult to navigate, especially as a trainee. PISA2020 offers a variety of opportunities to expand your professional network and to learn from a wide variety of professionals. In this session we will help trainees navigate the virtual meeting interface and cover exciting opportunities, such as education sessions, advertising yourself, and our special Meet-the-Expert session! This session will be moderated by senior trainee members of the ASIP and will ensure you will be able to have the best virtual conference experience! Session Moderators: Morgan Preziosi, PhD Roberto Mota Alvidrez, MD, MS Alexander Sougiannis, PhD |
Tuesday - November 10, 2020 |
|
9:00 AM - 10:00 AM (EST) |
Trainee Advising Session Gregory J. Tsongalis, PhD • Dartmouth-Hitchcock Health System |
Gene Expression Scientific Interest Group |
|
10:00 AM - 10:30 AM (EST) | Rong Fan, PhD • Yale School of Engineering and Applied Science "Spatial Omics Sequencing at the Cellular Level" |
10:30 AM - 11:00 AM (EST) | Robert Babak Faryabi, PhD • University of Pennsylvania “Alternative Perspectives to Multi-Omics Single-Cell Analysis” |
11:00 AM - 11:30 AM (EST) | Questions and Answers |
11:00 AM - 12:30 PM (EST) |
Lunch Session: Lunch with the Stars Pilar Alcaide, PhD Patricia D'Amore, PhD Andrew Duncan, PhD Christi Kolarcik, PhD William Muller, MD, PhD Kari Nejak-Bowen, PhD, MBA Magali Saint-Geniez, PhD Ronen Sumagin, PhD Xiao-Ming Yin, MD, PhD Elaine Bearer, MD, PhD, FAAAS, FCAP Wen-Xing Ding PhD, FAASLD Martha Furie, PhD Richard Mitchell, MD, PhD James Musser, MD, PhD George Perry, PhD Jennifer Sanders, PhD Qin Yan, PhD Qing Zhang, PhD |
12:30 PM - 1:00 PM (EST) | Break (View the ePosters) |
Plenary Session: Metabolism: From Organelles to Organisms Session Description: Metabolic homeostasis is key to health, and perturbations in metabolism are central to the pathogenesis of several diseases. The session “Metabolism: From Organelles to Organisms” will touch upon not only the key and timely aspects of the mechanisms that are the basis metabolic homeostasis but also how specific aberrations can have diverse pathological consequences. The world-renowned faculty will share their recent work on impact of parental health, environment and lifestyle on the health of offspring with an emphasis on metabolic consequences through epigenetic regulation. Likewise, the impact of thermogenesis in response to cold temperatures on energy expenditure and how it may have relevance in obesity related disorders such as non-alcoholic fatty liver disease, will be discussed. Similarly, how master transcriptional regulators like PGC1a, critical in regulating mitochondrial biogenesis and oxidative metabolism, control the metabolic programs in many tissues including muscle, will be discussed. All the speakers will also discuss the relevance of targeting key molecules for potential therapies. |
|
1:00 PM - 1:30 PM (EST) |
Mary-Elizabeth Patti, MD • Joslin Diabetes Center, Inc. Emerging evidence indicates that parental health can influence the health of offspring via both traditional genetic factors (DNA sequence) as well as via environmental factors such as lifestyle, nutrition, and activity levels. The impact of environmental factors may be particularly important if experienced during development (i.e. during intrauterine life) or during early childhood. These same environmental exposures can also influence developing germ cells – thus generating a potential vicious cycle of intergenerational risk of disease. While many individuals are familiar with the concept that maternal health is a key influence on child health, emerging data also demonstrate that the father’s health can also influence the sperm epigenome and thus contribute to offspring health. |
1:30 PM - 2:00 PM (EST) | David Cohen, MD, PhD • Weill Cornell Medicine “Towards New Molecular Targets for Non-Alcoholic Fatty Liver Disease: Phospholipid-Mediated Regulation of Hepatic Lipid and Glucose Metabolism” |
2:00 PM - 2:30 PM (EST) | Bruce Spiegelman, PhD • Harvard Medical School/Dana-Farber Cancer Institute “Energy Metabolism and Adipose Tissue” |
2:30 PM - 2:45 PM (EST) | Questions and Answers |
2:45 PM - 3:00 PM (EST) | Break |
Symposia: Host Protection and Responses to Infectious Diseases Session Description: Infectious diseases are a major cause of death and morbidity worldwide. To successfully prevent or target new, reemerging, and common infectious diseases, it is necessary to understand the complex relationships between pathogen and host. Collectively, the talks presented in this session will address key mechanisms used by viruses and bacteria to evade the host immune response. Recent advances in the understanding of host-pathogen interactions have yielded effective targets for vaccine and therapeutic intervention. |
|
3:00 PM - 3:30 PM (EST) | Frank DeLeo, PhD • National Institute of Allergy and Infectious Diseases “Klebsiella Pneumoniae-Host Interactions” |
3:30 PM - 4:00 PM (EST) | Elke Mühlberger, PhD • Boston University School of Medicine “The Inflammatory Response in Ebola Virus Infection” |
4:00 PM - 4:15 PM (EST) |
Abstract-Driven Short Talk |
4:15 PM - 4:30 PM (EST) |
Abstract-Driven Short Talk |
4:30 PM - 4:45 PM (EST) |
Abstract-Driven Short Talk |
4:45 PM - 5:00 PM (EST) | Questions and Answers |
Symposia: Deconstructing the Vascular System: Multi-Scale Approaches Session Description: This Symposia will explore novel experimental approaches for studying the vascular system in health and disease, and discuss how these approaches have led to a better mechanistic understanding of several vascular pathologies including atherosclerosis and diabetes. Novel insights into vascular integrity and remodeling in disease settings will also be presented. Moreover, we will address how these multiscale approaches are driving the identification of new therapeutic target for diagnosis and treatment of cardiovascular disease. |
|
3:00 PM - 3:25 PM (EST) | Joseph Arboleda-Velasquez, MD, PhD • Schepens Eye Research Institute “Integrity of Vasculature in the Diabetic Environment” |
3:25 PM - 3:50 PM (EST) | Eno Ebong, PhD • Northeastern University “Glycocalyx-Mediated Vascular Remodeling and Permeability in Disturbed Flow” |
3:50 PM - 4:15 PM (EST) | Yajaira Suarez, PhD • Yale University School of Medicine “MicroRNA Regulation of Atherosclerosis” |
4:15 PM - 4:25 PM (EST) |
Abstract-Driven Short Talk |
4:25 PM - 4:35 PM (EST) |
Abstract-Driven Short Talk |
4:35 PM - 4:45 PM (EST) |
Abstract-Driven Short Talk |
4:45 PM - 5:00 PM (EST) | Questions and Answers |
5:00 PM - 6:00 PM (EST) | Break (View the ePosters) |
6:00 PM - 8:00 PM (EST) |
Women in Pathology (WiP) "Jeopardy" The pandemic has detrimentally impacted mental health and wellness as career and home workloads expanded. Join us for a fun break to learn more about Women in Pathology and about the history of women in the ASIP. This is not just for women! Men, please show your support for this blooming group of amazing women while you have fun and a chance to win prizes! Don't miss this networking opportunity for a vivid discussion and game! Session Moderators: Linda McManus, PhD Pilar Alcaide, PhD Nakisha Rutledge, BSC |
Wednesday - November 11, 2020 |
|
8:00 AM - 9:00 AM (EST) |
Trainee Advising Session Richard N. Mitchell, MD, PhD • Brigham & Women's Hospital |
9:00 AM - 10:00 AM (EST) |
Trainee Advising Session Traci L. Parry, PhD • University of North Carolina at Greensboro |
Breast Cancer Scientific Interest Group Meet-the-Expert Session |
|
10:00 AM - 10:45 AM (EST) | Breast Cancer Scientific Interest Group Meet-the-Expert Session Celina Kleer, MD • University of Michigan "Understanding Breast Cancer: My Journey as a Physician Scientist" |
10:45 AM - 11:30 AM (EST) | Questions and Answers |
Liver Pathobiology Scientific Interest Group |
|
10:00 AM - 10:30 AM (EST) | David Cohen, MD, PhD • Weill Cornell Medicine "NAFLD: Cellular and Molecular Basis and Therapies" |
10:30 AM - 11:00 AM (EST) | Jan Tchorz, PhD • Novartis Institutes "Liver Homeostasis, Zonation and Repair" |
11:00 AM - 11:30 AM (EST) | Questions and Answers |
11:30 AM - 1:00 PM (EST) | Break (View the ePosters) |
Plenary Session: Bench to Bedside: NOT Lost in Translation |
|
1:00 PM - 1:30 PM (EST) |
Joan Miller, MD • Massachusetts Eye & Ear Infirmary The development and approval of anti-vascular endothelial growth factor (VEGF) drugs for retinal diseases has completely changed the field of ophthalmology—improving vision outcomes and quality of life for millions of people around the world. In this lecture, we will we will revisit the pathway to the successful development of anti-VEGF therapies and discuss the hurdles and strategies needed to move potential therapies from bench to bedside. |
1:30 PM - 2:00 PM (EST) |
Christina Lockwood, PhD, DABCC, DABMGG • University of Washington The earliest report of cell-free DNA in healthy individuals dates to the 1940s and it has been most widely adopted in medicine in assessing fetal risk of chromosomal abnormalities in pregnant women. In oncology, there are a variety of clinical applications for a minimally invasive blood test for DNA released from tumor cells. The increased adoption of targeted cancer therapies underscores the need to augment invasive tissue biopsies with alternative detection methods that rapidly monitor treatment response. In this lecture, we will review the clinical indications for cell-free DNA and discuss the opportunities and challenges associated with cell-free DNA testing in pregnancy and oncology. |
2:00 PM - 2:30 PM (EST) |
Mark Puder, MD, PhD • Boston Children's Hospital Many children are unable to tolerate or absorb nutrients and require intravenous nutrition (parenteral nutrition). Parenteral nutrition contains sugar, amino acids, lipids, vitamins and trace elements. This nutrition is life-saving, however up to 60% of infants develop intestinal failure associated liver disease (parenteral nutrition associated liver disease) that was responsible for 1.4% of all deaths in children age 4 years and under. This disease was one of the main indications for liver and multivisceral transplants in children. At the time, the actual component(s) of the parenteral nutrition producing the liver disease was unknown. We will discuss the laboratory experiments to understand the etiology (lipids) and the pathway to FDA approval of alternative lipid emulsions in treating this often fatal disease. |
2:30 PM - 2:45 PM (EST) | Questions and Answers |
2:45 PM - 3:00 PM (EST) | Break |
Symposia: Not a Monolithic Disease: Cancer Heterogeneity and Precision Oncology Session Description: Novel genetic and epigenetic changes in the tumor as well as the specific tissue microenvironment underlie the unique nature of tumor development, progression and response. Cancer therapy is challenging due to genetic heterogeneity of tumors, the diversity of pathways used by different tumors, and the relentless evolution of drug resistance. Nongenetic heterogeneity is also critical consideration as cells respond to broad, environmental perturbations and drug treatments. Big data technologies have expanded our abilities to characterize and model individual tumor and patient responses. In this symposium, we will discuss the contribution and mechanisms by which differences in the tumor and host genome, epigenome and tumor microenvironment regulate tumor evolution and individual patient response to therapy. We will also delve into how the knowledge generated by big data combined with artificial intelligence and machine learning approaches can lead to advances in more precise diagnostic and therapeutic options for patients. |
|
3:00 PM - 3:30 PM (EST) | Laura van't Veer, PhD • University of California, San Francisco “Matching Targeted Therapies to the Biology of Disease in Breast Cancer” |
3:30 PM - 4:00 PM (EST) | Simona Cristea, PhD • Harvard University “Unravelling Subclonal Heterogeneity and Aggressive Disease States in Triple Negative Breast Cancer Through Single-Cell RNA-Seq" |
4:00 PM - 4:15 PM (EST) |
Abstract-Driven Short Talk |
4:15 PM - 4:30 PM (EST) |
Abstract-Driven Short Talk |
4:30 PM - 4:45 PM (EST) |
Abstract-Driven Short Talk |
4:45 PM - 5:00 PM (EST) | Questions and Answers |
Symposia: And the Beat Goes On: New Wrinkles in Cardiovascular Pathophysiology Session Description: This symposium will cover two important and evolving topics in cardiovascular pathophysiology, the genetics of sudden death and the role of inflammation in atherosclerosis. Sudden unexpected cardiac death strikes without warning, killing both young and old. While some genetic variants have long been associated with sudden cardiac death, the wider application of whole genome sequencing in those who experience sudden cardiac death is opening up new avenues for research into this phenomenon; but it is also creating complexities into understanding the true pathogenicity of newly identified genetic variants. Atherosclerosis remains a leading cause of death world-wide. Through both animal modelling and human studies inflammation promoted by interleukin-1 has been identified as a key driver of this pervasive condition. A detailed understanding of the inflammatory response in the vessel wall during atherogenesis offers the potential for the development of novel and selective approaches to treat this deadly condition. |
|
3:00 PM - 3:30 PM (EST) | Heidi Rehm, PhD • Broad Institute/Massachusetts General Hospital/Brigham and Women’s Hospital/Harvard Medical School “Curating the Clinical Genome on a Global Scale” |
3:30 PM - 4:00 PM (EST) | Peter Libby, MD • Brigham & Women's Hospital and Harvard Medical School “Interleukin-1 in Atherosclerosis: A Translational Journey” |
4:00 PM - 4:15 PM (EST) |
Abstract-Driven Short Talk |
4:15 PM - 4:30 PM (EST) |
Abstract-Driven Short Talk |
4:30 PM - 4:45 PM (EST) |
Abstract-Driven Short Talk |
4:45 PM - 5:00 PM (EST) | Questions and Answers |
Navigating the Socialsphere: A How-to Guide for Promoting Your Scientific Career Online Organizers: Session Description: Let's celebrate the rapid rise of scientific content and scientists on social media, strategize for the future and become the scientific champion of your science needs by amplifying your research online. |
|
6:00 PM - 6:10 PM (EST) | Welcome & Introductions |
6:10 PM - 6:25 PM (EST) | Daisy Shu, PhD • Harvard University “How to Get Started on Social Media and Build a Following” |
6:25 PM - 6:40 PM (EST) | Eric Perkins, PhD • Addgene “Promoting Your Brand (of Science) on Social Media” |
6:40 PM - 6:55 PM (EST) | Daniel Camarda, MS • Harvard University “Best Practices for Social Media Usage, an Institutional Perspective” |
7:00 PM - 7:30 PM (EST) | Panel Discussions, Break-out Rooms Break-out Room 1 - "Social Starters" (Beginning Users) Break-out Room 2 - "Social Pros" (Intermediate & Advanced Users) |
Thursday - November 12, 2020 |
|
8:00 AM - 9:00 AM (EST) |
Trainee Advising Session Morgan Preziosi, PhD • Chimeron Biotech |
9:00 AM - 10:00 AM (EST) |
Trainee Advising Session Veronica Contreras-Shannon, PhD • St. Mary's University |
10:00 AM - 11:00 AM (EST) |
Trainee Advising Session Andrew Duncan, PhD • University of Pittsburgh |
11:00 AM - 1:00 PM (EST) |
Lunch Session: Pathology Career Pathway Networking Session Description: Seeking to transition into or learn more about the dynamic careers in the biotechnology industry? Thinking about the next steps in your pathology career? This networking session is designed to connect you with leading experts in the biotechnology field. Panelists were chosen from a vast array of companies (many local to the Boston area) and range from product sales and distribution to bench scientists to group leaders to company founders and CEOs. This lunch session will function similar to a speed networking session where small groups will interact with the panelists for approximately 15 minutes in separate breakout rooms. Feel free to ask questions or obtain career advice. This networking session is ideal for trainees at all levels including undergraduates, graduate students, post-doctoral fellows, residents, and junior faculty. Zeev Gechtman, PhD Mark Kieran, MD, PhD Morgan Preziosi, PhD Michelle Le Blanc, PhD Jared Iacovelli, PhD Sumana Chintalapudi, PhD Randy Watnick, PhD Lindsay Wong Jeffrey Johnson, PhD Cassandra Rogers Marya Chaney, PhD Steven Pirie-Shepherd, PhD Joshua Judkins, PhD Lorna Cryan, PhD |
Plenary Session: Computational Pathology: Big Data, Big Ideas Translation Co-Chairs: Session Description: Big data has referred to the means to acquire and analyze new, complex and multi-dimensional sources of information. Novel tools to extract meaning from ‘big data’ have the potential to drive substantive changes in clinical practice, from personalized diagnostics, prognostics and therapeutics to intelligent drug design, population surveillance/screening and the mining of the electronic health record. Successful integration of data analytics and data sciences within platforms for biomedical discovery are expanding further innovations and applications to patient care. |
|
1:00 PM - 1:30 PM (EST) | Andrew Beck, MD, PhD • PathAI “AI and Pathology Imaging” |
1:30 PM - 2:00 PM (EST) | Lynn Bry, MD, PhD • Harvard Medical School/Brigham and Women's Hospital “Microbiome and Applications of Big Data” |
2:00 PM - 2:30 PM (EST) | Mario Suva, MD, PhD • Harvard Medical School/Massachusetts General Hospital/The Broad Institute of MIT “Dissecting Brain Tumors by Single-Cell Genomics” |
2:30 PM - 2:45 PM (EST) | Questions and Answers |
2:45 PM - 3:00 PM (EST) | Break |
Symposia: New Horizons for Neutrophils and Monocytes in Mucosal and Vascular Cell Biology Session Description: Monocytes and neutrophils play key roles in the pathogenesis of many diseases. Monocytes undergo a continuum of phenotypic and functional changes in response to inflammatory cues. The first presentation identified mechanisms that drive monocyte to macrophage differentiation in glomerulonephritis, an autoimmune disease of the kidney. Leukocyte adhesion and migration requires rapid actin dynamics. The second presentation studied the function of the cortactin homologue HS1 in neutrophils using two different murine models: intravital microscopy of the inflamed cremaster microcirculation and experimental colitis. |
|
3:00 PM - 3:30 PM (EST) | Tanya Mayadas, PhD • Brigham and Women's Hospital “Molecular Control of Monocyte Maturation During Inflammation” |
3:30 PM - 4:00 PM (EST) | Michael Schnoor, PhD • Centro de Investigacion y de Estudios (CINVESTAV) "The Actin-Binding Protein HS1 Regulates Neutrophil Recruitment Patterns During Inflammation" |
4:00 PM - 4:15 PM (EST) |
Abstract-Driven Short Talk |
4:15 PM - 4:30 PM (EST) |
Abstract-Driven Short Talk |
4:30 PM - 4:45 PM (EST) |
Abstract-Driven Short Talk |
4:45 PM - 5:00 PM (EST) | Questions and Answers |
Symposia: Molecular Diagnostics: The Liquid Biopsy Session Description: This session will give an overview of the current applications of liquid biopsy to solid tumors. The liquid biopsy has been shown to be a surrogate for tissue biopsy in several scenarios and could be used more frequently to monitor response to therapy and disease progression. To date these applications seem very promising but liquid biopsy testing has yet to become routine practice in part due to the non-standardization of this technology and lack of clear clinical interpretation of low allelic frequency variants. This session will feature two invited speakers (Dr John Iafrate from Massachusetts General Hospital and Dr. Joshua Coleman from ARUP Laboratories), as well as several abstract-driven talks. Dr. Iafrate will discuss circulating tumor DNA and possible applications for detection of such in non-invasive cancer molecular diagnostics. Dr. Coleman will discuss the liquid biopsy and its value in detection of solid cancers. The abstract-driven talks will be based upon submitted research in the area of cancer molecular diagnostics. |
|
3:00 PM - 3:30 PM (EST) | A. John Iafrate, MD • Massachusetts General Hospital “ctDNA: Practical Realities and Future Applications" |
3:30 PM - 4:00 PM (EST) | Joshua F. Coleman, MD • University of Utah Health "Liquid Biopsy: Emerging Applications for Solid Tumors" |
4:00 PM - 4:15 PM (EST) |
Abstract-Driven Short Talk |
4:15 PM - 4:30 PM (EST) |
Abstract-Driven Short Talk |
4:30 PM - 4:45 PM (EST) |
Abstract-Driven Short Talk |
4:45 PM - 5:00 PM (EST) | Questions and Answers |
Friday - November 13, 2020 |
|
8:00 AM - 9:00 AM (EST) |
Trainee Advising Session Richard N. Mitchell, MD, PhD • Brigham & Women's Hospital |
9:00 AM - 10:00 AM (EST) |
Trainee Advising Session Patricia D’Amore, PhD • Schepens Eye Research Institute/Harvard Medical School |
10:00 AM - 12:00 PM (EST) |
Panel Discussions - COVID-19 Updates from Frontline Experts Moderator: Chhavi Chauhan, PhD, ELS
James Musser, MD, PhD L. Maximilian Buja, MD Helen Fernandes, PhD Richard S. Vander Heide, MD, PhD, MBA Jody E. Hooper, MD Charles Parkos, MD, PhD |
Plenary Session: Architectural Models of Disease: Rendering Complexity on a Small Scale Session Description: Experimental models allow empirical research in physiologic and pathophysiologic processes. In this symposium, we highlight innovative models that deliver high levels of complexity that allow of dissection and modification of complicated, interactive biological systems, while also providing measures of efficiency and affordability and addressing the three “Rs” tenet of animal modeling (Replacement, Reduction, and Refinement). The first presentation of this symposium will focus on the emerging use of Zebrafish as vertebrate models for metabolic and neoplastic diseases of the liver and pancreas. The second presentation will delve into molecular mechanisms that modify the hallmark traits of aging and result in vast differences in lifespan across rodent species. The third presentation will describe stem cell engineering strategies for in vitro manufacture of mature, functional populations of blood components for preclinical studies and eventual clinical use. |
|
1:00 PM - 1:30 PM (EST) | Wolfram Goessling, MD, PhD • Harvard Stem Cell Institute “Liver Regeneration: Fate and Function” |
1:30 PM - 2:00 PM (EST) | Vera Gorbunova, PhD • University of Rochester “Mechanisms of Longevity in Naked Mole Rats and Other Long-Lived Rodents” |
2:00 PM - 2:30 PM (EST) | George Daley, MD, PhD • Harvard Medical School/Children's Hospital Boston “Blood From a Petri Dish” |
2:30 PM - 2:45 PM (EST) | Questions and Answers |
2:45 PM - 3:00 PM (EST) | Break |
Symposia: Host-Microbial Interactions at the Mucosal Surfaces Session Description: Mucosal epithelia create critical interfaces and protective barriers to interact with commensal microbes and prevent pathogen invasion. This symposium will present recent advances in understanding the mechanisms that regulate host-microbial cross-talk at different mucosal surfaces. The first talk will be dedicated to local immune mechanisms that protect against HIV in the female genital tract, with specific focus on neutrophils and neutrophil extracellular traps. The second talk will be focused on the intestinal mucosa and will describe the roles of natural killer T (NKT) cells in regulating gut microbial commensalism and response to pathogens. Age dependent and microbiome dependent mechanisms of NKT cell regulation will also be discussed. |
|
3:00 PM - 3:30 PM (EST) | Marta Rodriguez-Garcia, MD, PhD • Tufts University School of Medicine “The Role of Neutrophils in HIV Prevention in the Female Genital Tract” |
3:30 PM - 4:00 PM (EST) | Richard "Rick" Blumberg, MD • Brigham and Women's Hospital/Harvard “NKT Cells at the Mucosal Interface” |
4:00 AM - 4:15 PM (EST) |
Abstract-Driven Short Talk |
4:15 AM - 4:30 PM (EST) |
Abstract-Driven Short Talk |
4:30 AM - 4:45 PM (EST) |
Abstract-Driven Short Talk |
4:45 AM - 5:00 PM (EST) | Questions and Answers |
Symposia: Lymphatic Biology, Obesity, and Beyond Session Description: The lymphatic vascular system is a unidirectional conduit to recycle protein-rich lymph in the interstitial space back to the venous system. Lymphatics regulate interstitial fluid volumes to prevent edema, transport antigens to lymph nodes, facilitate immune cell traffic to and from lymph nodes, and absorb dietary fats in the intestines. The structure and morphology of lymphatic vessels and the cell-cell junctions present between lymphatic endothelial cells are crucial to vessel integrity and proper lymphatic function. Despite the well-established role that lacteals play in the absorption of dietary fat in the intestines, the role of lymphatic junctional remodeling and its impact on obesity and inflammatory diseases such as metabolic syndrome have only recently been recognized. Presentations in this session will discuss mechanisms regulating lymphatic function in health and disease and explore the bidirectional relationship between obesity and the lymphatic system. |
|
3:00 PM - 3:30 PM (EST) | Hong Chen, PhD • Harvard Medical School/Boston Children's Hospital “Mechanisms of Foxc2-Mediated Regulation of Lymphatic Function in Metabolic Diseases” |
3:30 PM - 4:00 PM (EST) | Anne Eichmann, PhD • Yale University School of Medicine “Lacteal Junctions as Regulators of Plasma Lipid Uptake and Obesity” |
4:00 PM - 4:15 PM (EST) |
Abstract-Driven Short Talk |
4:15 PM - 4:30 PM (EST) |
Abstract-Driven Short Talk |
4:30 PM - 4:45 PM (EST) |
Abstract-Driven Short Talk |
4:45 PM - 5:00 PM (EST) | Questions and Answers |
5:00 PM - 5:30 PM (EST) | Closing Remarks |